Global Genes RARE Partnering and Investor Forum Coming to Irvine 9/14

In The Ecosystem
September 11, 2017 By Applied Innovation

The RARE Partnering and Investor Forum is a one-of-a-kind, one-day event taking place in Irvine on September 14, 8am-5pm, focused on bringing together innovators and investors to drive advances in Rare Disease. Attendees will hear insights on trends from industry insiders, take advantage of 1:1 partnering opportunities, and see a ‘Shark-Tank’-like, fast-pitch competition.

Attendees include:
• Art Pappas, Pappas Ventures
• Ashish Sagrolikar, Office of Commercial Transformation, GSK
• Bharatt Chowrira, President, PureTech Health
• Camille Samuels, Managing Partner, Venrock
• Chris Adams, CEO, Cydan
• Dan Bobear, President and Founder, Patient Experience Project
• Jeremy Springhorn, Formerly Managing Partner, Flagship Pioneering
• John Crowley, CEO Amicus Therapeutics
• Karen Erickson, Alpha-1 Project and Alpha -1 Foundation
• Kush Parmar, Managing Partner, 5AM Ventures
• Michael Broxson, VP and Head of R&D Business Development, Takeda Pharmaceuticals
• Mike Pistone, Director of Business Development & Marketing, Center for Technology Commercialization Cincinnati Children’s
• Molly Harper, VP Commercial Development, Akcea
• Neil Kumar, CEO, Bridgebio
• Vern Norviel, Partner, Wilson Sonsini Goodrich & Rosati

Panel discussions include:
• Innovative Company Creation Models for Rare Diseases
• Alternatives to Standard Newcos: Spin-offs, Build-to-Buys, Joint Ventures and Alliances
• How to Ensure a Successful Commercial Launch of a Rare Disease Therapeutic
• Overcoming the Development Challenges of a Rare Disease Therapeutic
• Rare Disease Partnering Among Advocates, Academics, Startups and Global Pharma Companies

Click here for more details and to register today.